logo

For the Inventor, By the Inventor

Ste-Julie, Canada

Alexandre L'Heureux

This inventor holds 10 USPTO granted patents and 2 EPO patents. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2004-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexandre L'Heureux. Retrieved from https://idiyas.com/inventor/alexandre-l-heureux

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 10

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.6

ph-index = 4

Forward Citations = 64(Granted Patents)


Location History:

  • Longueuil, CA (2004 - 2006)
  • Ste-Julie, CA (2008 - 2017)

Company Filing History:

goldMedal10 out of 3,745 
 
Bristol-Myers Squibb Compnay
 patents

Years Active: 2004-2017

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 9540323 - [object Object] (2017-01-10),
2. 8273772 - [object Object] (2012-09-25),
3. 7674828 - [object Object] (2010-03-09),
4. 7645778 - [object Object] (2010-01-12),
5. 7388021 - [object Object] (2008-06-17),
6. 7144881 - Arylcyclopropylcarboxylic amides as potassium channel openers (2006-12-05),
7. 7135472 - 3-Heterocyclic benzylamide derivatives as potassium channel openers (2006-11-14),
8. 7045551 - 1-aryl-2-hydroxyethyl amides as potassium channel openers (2006-05-16),
9. 6969717 - Azaindole kinase inhibitors (2005-11-29),
10. 6831080 - Cinnamide derivatives as KCNQ potassium channel modulators (2004-12-14),

Title: The Innovations of Alexandre L'Heureux

Introduction

Alexandre L'Heureux, an accomplished inventor based in Ste-Julie, Canada, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 10 patents, he has focused his efforts on developing novel compounds aimed at enhancing medical treatments.

Latest Patents

Among his latest innovations, L'Heureux has produced compounds that are antagonists of the P2Y receptor, which are essential in creating effective medicaments. His patented inventions include novel heteroaryl compounds and their analogues that act as selective inhibitors of the human P2Y receptor. These compounds are pivotal in the formulation of various pharmaceutical compositions and present new methods for treating diseases responsive to the modulation of P2Y receptor activity.

Career Highlights

Currently, Alexandre L'Heureux is a key inventor at Bristol-Myers Squibb Company, a leading biopharmaceutical firm. His career is marked by a dedication to pharmaceutical innovations that potentially transform healthcare.

Collaborations

Throughout his career, L'Heureux has collaborated with notable colleagues such as Rejean Ruel and Patrick Y. S. Lam. Together, they have engaged in cutting-edge research that supports significant advancements in their field.

Conclusion

With his impressive track record of patents and collaborations, Alexandre L'Heureux continues to be a vital figure in pharmaceutical innovation. His research and inventions hold promise for the future of medical treatment, showcasing the importance of creativity and scientific inquiry in addressing health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…